The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.
| Level | Code | Title | |
|---|---|---|---|
1
|
V | Various | |
2
|
V03 | All other therapeutic products | |
3
|
V03A | All other therapeutic products | |
4
|
V03AF | Detoxifying agents for antineoplastic treatment | |
5
|
V03AF09 | Glucarpidase |
| Active Ingredient |
|---|
|
Glucarpidase is a recombinant bacterial enzyme that hydrolyses the carboxyl-terminal glutamate residue from folic acid and structurally related molecules such asMTX. Glucarpidase converts MTX to its inactive metabolites DAMPA and glutamate. |
| Document | Type | Information Source | |
|---|---|---|---|
| VORAXAZE Powder for solution for injection | MPI, US: SPL/PLR | FDA, National Drug Code (US) | |
| VORAXAZE Powder for solution for injection | MPI, EU: SmPC | European Medicines Agency (EU) |
Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.